Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury

Experimental Neurology

Volumn 235, Issue 1, 2012, Pages 174-187

  Andrews, Ellen M ^a   Richards, Rebekah J ^a   Yin, Feng Q ^a   Viapiano, Mariano S ^a   Jakeman, Lyn B ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Aggrecan; CSPG; Neurocan; NG2; Perineuronal net; Plasticity; Spinal cord injury

Indexed keywords

AGGRECAN; BIOLOGICAL MARKER; BREVICAN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROCAN; NG2 PROTEIN; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CERVICAL SPINAL CORD; CONTROLLED STUDY; CONTUSION; EXTRACELLULAR MATRIX; FEMALE; GRAY MATTER; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN; THORACIC SPINAL CORD; UPREGULATION; WESTERN BLOTTING; WHITE MATTER;

ANIMALS; ASTROCYTES; AXONS; CHONDROITIN SULFATE PROTEOGLYCANS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84859917115     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.09.008     Document Type: Article

References (103)

1. Afshari F.T., Kwok J.C., White L., Fawcett J.W. Schwann cell migration is integrin-dependent and inhibited by astrocyte-produced aggrecan. Glia. 2010, 58(7):857-869. PMID: 20155822.
2. Ankeny D.P., McTigue D.M., Jakeman L.B. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol. 2004, 190(1):17-31.
3. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 2000, 20:2427-2438.
4. Barritt A.W., Davies M., Marchand F., Hartley R., Grist J., Yip P., McMahon S.B., Bradbury E.J. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 2006, 26:10856-10867.
5. Bekku Y., Rauch U., Ninomiya Y., Oohashi T. Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS. J. Neurochem. 2009, 108:1266-1276.
6. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., Maroon J., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 1990, 322:1405-1411.
7. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
8. Bresnahan J.C., Beattie M.S., Stokes B.T., Conway K.M. Three-dimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat. J. Neurotrauma 1991, 8(2):91-101.
9. Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., Quencer R.M. Observations on the Pathology of Human Spinal Cord Injury: A Review and Classification of 22 New Cases with Details from a Case of Chronic Cord Compression with Extensive Focal Demyelination 1993, 75-89. Advances in Neurology Raven Press, New York. F.J. Seil (Ed.).
10. Buss A., Brook G.A., Kakulas B., Martin D., Franzen R., Schoenen J., Noth J., Schmitt A.B. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 2004, 127:34-44.
11. Buss A., Pech K., Kakulas B.A., Martin D., Schoenen J., Noth J., Brook G.A. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury. Brain 2007, 130:940-953.
12. Buss A., Pech K., Kakulas B.A., Martin D., Schoenen J., Noth J., Brook G.A. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. BMC Neurol. 2009, 9:32.
13. Carulli D., Pizzorusso T., Kwok J.C., Putignano E., Poli A., Forostyak S., Andrews M.R., Deepa S.S., Glant T.T., Fawcett J.W. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010, 133:2331-2347.
14. Chan C.C., Roberts C.R., Steeves J.D., Tetzlaff W. Aggrecan components differentially modulate nerve growth factor-responsive and neurotrophin-3-responsive dorsal root ganglion neurite growth. J. Neurosci. Res. 2008, 86:581-592.
15. Chen Z.J., Ughrin Y., Levine J.M. Inhibition of axon growth by oligodendrocyte precursor cells. Mol. Cell. Neurosci. 2002, 20(1):125-139.
16. Chiodo A.E., Scelza W.M., Kirshblum S.C., Wuermser L.A., Ho C.H., Priebe M.M. Spinal cord injury medicine. 5. Long-term medical issues and health maintenance. Arch. Phys. Med. Rehabil. 2007, 88:S76-S83.
17. Coles C.H., Shen Y., Tenney A.P., Siebold C., Sutton G.C., Lu W., Gallagher J.T., Jones E.Y., Flanagan J.G., Aricescu A.R. Proteoglycan-specific molecular switch for RPTPsigma clustering and neuronal extension. Science 2011, 332:484-488.
18. Courtine G., Gerasimenko Y., van den B.R., Yew A., Musienko P., Zhong H., Song B., Ao Y., Ichiyama R.M., Lavrov I., Roy R.R., Sofroniew M.V., Edgerton V.R. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat. Neurosci. 2009, 12:1333-1342.
19. Davies S.J., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 1999, 19:5810-5822.
20. Dityatev A., Brückner G., Dityateva G., Grosche J., Kleene R., Schachner M. Activity-dependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. Dev. Neurobiol. 2007, 67(5):570-588.
21. Dityatev A., Schachner M., Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat. Rev. Neurosci. 2010, 11:735-746.
22. Dityatev A., Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosci. 2003, 4:456-468.
23. Dou C.L., Levine J.M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 1994, 14:7616-7628.
24. Duan Y., Giger R.J. A new role for RPTPsigma in spinal cord injury: signaling chondroitin sulfate proteoglycan inhibition. Sci. Signal. 2010, 3:e6.
25. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 2008, 209(2):294-301.
26. Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 1997, 148:587-603.
27. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
28. Fouad K., Schnell L., Bunge M.B., Schwab M.E., Liebscher T., Pearse D.D. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 2005, 25:1169-1178.
29. Friedlander D.R., Milev P., Karthikeyan L., Margolis R.K., Margolis R.U., Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J. Cell Biol. 1994, 125:669-680.
30. Galtrey C.M., Kwok J.C., Carulli D., Rhodes K.E., Fawcett J.W. Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord. Eur. J. Neurosci. 2008, 27:1373-1390.
31. Garcia-Alias G., Barkhuysen S., Buckle M., Fawcett J.W. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 2009, 12:1145-1151.
32. Giamanco K.A., Morawski M., Matthews R.T. Perineuronal net formation and structure in aggrecan knockout mice. Neuroscience 2010, 170:1314-1327.
33. Gilbert R.J., McKeon R.J., Darr A., Calabro A., Hascall V.C., Bellamkonda R.V. CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol. Cell. Neurosci. 2005, 29(4):545-558.
34. Grimpe B., Silver J. A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J. Neurosci. 2004, 24(6):1393-1397.
35. Harris N.G., Carmichael S.T., Hovda D.A., Sutton R.L. Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited. J. Neurosci. Res. 2009, 87:2937-2950.
36. Haas C.A., Rauch U., Thon N., Merten T., Deller T. Entorhinal cortex lesion in adult rats induces the expression of the neuronal chondroitin sulfate proteoglycan neurocan in reactive astrocytes. J Neurosci. 1999, 19(22):9953-9963.
37. Ho C.H., Wuermser L.A., Priebe M.M., Chiodo A.E., Scelza W.M., Kirshblum S.C. Spinal cord injury medicine. 1. Epidemiology and classification. Arch. Phys. Med. Rehabil. 2007, 88:S49-S54.
38. Hockfield S., Kalb R.G., Zaremba S., Fryer H. Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harb. Symp. Quant. Biol. 1990, 55:505-514.
39. Hossain-Ibrahim M.K., Rezajooi K., Stallcup W.B., Lieberman A.R., Anderson P.N. Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse. BMC Neurosci. 2007, 8:80.
40. Houle J.D., Tom V.J., Mayes D., Wagoner G., Phillips N., Silver J. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J. Neurosci. 2006, 26:7405-7415.
41. Hu B., Kong L.L., Matthews R.T., Viapiano M.S. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J. Biol. Chem. 2008, 283:24848-24859.
42. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ 2003, 168:1145-1146.
43. Hurtado A., Podinin H., Oudega M., Grimpe B. Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord. Brain 2008, 131(Pt 10):2596-2605.
44. Iaci J.F., Vecchione A.M., Zimber M.P., Caggiano A.O. Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment. J. Neurotrauma 2007, 24:1743-1759.
45. Jakeman L.B., Wei P., Guan Z., Stokes B.T. Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury. Exp Neurol. 1998, 154(1):170-184.
46. Jakeman L.B., Hoschouer E.L., Basso D.M. Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury. Brain Res. Bull. 2011, 84(4-5):317-326.
47. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 2003, 182:399-411.
48. Jones L.L., Yamaguchi Y., Stallcup W.B., Tuszynski M.H. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 2002, 22:2792-2803.
49. Jones L.L., Sajed D., Tuszynski M.H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J. Neurosci. 2003, 23:9276-9288.
50. Kakulas B.A. A review of the neuropathology of human spinal cord injury with emphasis on special features. J. Spinal Cord Med. 1999, 22:119-124.
51. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Schut D., Fehlings M.G. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J. Neurosci. 2010, 30:1657-1676.
52. Kim B.G., Dai H.N., Lynskey J.V., McAtee M., Bregman B.S. Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats. J. Comp. Neurol. 2006, 497:182-198.
53. Kwok J.C., Afshari F., Garcia-Alias G., Fawcett J.W. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor. Neurol. Neurosci. 2008, 26:131-145.
54. Kwon B.K., Hillyer J., Tetzlaff W. Translational research in spinal cord injury: a survey of opinion from the SCI community. J. Neurotrauma 2010, 27:21-33.
55. Laabs T.L., Wang H., Katagiri Y., McCann T., Fawcett J.W., Geller H.M. Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans. J. Neurosci. 2007, 27(52):14494-14501.
56. Lemons M.L., Howland D.R., Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp. Neurol. 1999, 160:51-65.
57. Lemons M.L., Sandy J.D., Anderson D.K., Howland D.R. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury. J. Neurosci. 2001, 21:4772-4781.
58. Lemons M.L., Sandy J.D., Anderson D.K., Howland D.R. Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord. Exp. Neurol. 2003, 184:981-990.
59. Lin R., Rosahl T.W., Whiting P.J., Fawcett J.W., Kwok J.C. 6-Sulphated chondroitins have a positive influence on axonal regeneration. PLoS One 2011, 6(7):e21499.
60. Mangin J.M., Gallo V. The curious case of NG2 cells: transient trend or game changer?. ASN Neuro. 2011, 3.
61. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G., Silver J., Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 2008, 209:426-445.
62. Matthews R.T., Kelly G.M., Zerillo C.A., Gray G., Tiemeyer M., Hockfield S. Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J. Neurosci. 2002, 22:7536-7547.
63. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 1995, 136:32-43.
64. McKeon R.J., Jurynec M.J., Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 1999, 19:10778-10788.
65. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction in neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 1991, 11:3398-3411.
66. McRae P.A., Rocco M.M., Kelly G., Brumberg J.C., Matthews R.T. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J. Neurosci. 2007, 16(20):5405-5413. 27.
67. McTigue D.M., Tripathi R., Wei P. NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. J. Neuropathol. Exp. Neurol. 2006, 65:406-420.
68. Metz G.A., Curt A., van de Meent H., Klusman I., Schwab M.E., Dietz V. Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. J. Neurotrauma 2000, 17(1):1-17.
69. Milev P., Maurel P., Chiba A., Mevissen M., Popp S., Yamaguchi Y., Margolis R.K., Margolis R.U. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem. Biophys. Res. Commun. 1998, 247:207-212.
70. Mize R.R., Hockfield S. Cat-301 antibody selectively labels neurons in the Y-innervated laminae of the cat superior colliculus. Vis Neurosci. 1989, 3(5):433-443.
71. Monnier P.P., Sierra A., Schwab J.M., Henke-Fahle S., Mueller B.K. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell. Neurosci. 2003, 22:319-330.
72. Nishiyama A., Lin X.H., Giese N., Heldin C.H., Stallcup W.B. Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. Res. 1996, 43:299-314.
73. Noble L.J., Wrathall J.R. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp. Neurol. 1985, 88:135-149.
74. Nooijen C.F., Ter H.N., Field-Fote E.C. Gait quality is improved by locomotor training in individuals with SCI regardless of training approach. J. Neuroeng. Rehabil. 2009, 6:36.
75. Norenberg M.D., Smith J., Marcillo A. The pathology of human spinal cord injury: defining the problems. J. Neurotrauma 2004, 21:429-440.
76. Poon P.C., Gupta D., Shoichet M.S., Tator C.H. Clip compression model is useful for thoracic spinal cord injuries: histologic and functional correlates. Spine 2007, 32:2853-2859.
77. Properzi F., Carulli D., Asher R.A., Muir E., Camargo L.M., van Kuppevelt T.H., Ten Dam G.B., Furukawa Y., Mikami T., Sugahara K., Toida T., Geller H.M., Fawcett J.W. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur. J. Neurosci. 2005, 21:378-390.
78. Rabchevsky A.G., Fugaccia I., Sullivan P.G., Scheff S.W. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 2001, 18:513-522.
79. Rauch U. Extracellular matrix components associated with remodeling processes in brain. Cell Mol. Life Sci. 2004, 61:2031-2045.
80. Rauch U., Feng K., Zhou X.H. Neurocan: a brain chondroitin sulfate proteoglycan. Cell Mol. Life Sci. 2001, 58:1842-1856.
81. Reier P.J., Eng L.F., Jakeman L. Reactive astrocyte and axonal outgrowth in the injured CNS: is gliosis really an impediment to regeneration?. Neural Regeneration and Transplantation 1989, 183-209. Alan R. Liss, Inc., New York. F.J. Seil (Ed.).
82. Retzler C., Göhring W., Rauch U. Analysis of neurocan structures interacting with the neural cell adhesion molecule N-CAM. J. Biol. Chem. 1996, 271(44):27304-27310.
83. Sakry D., Karram K., Trotter J. Synapses between NG2 glia and neurons. J. Anat. 2011, 219(1):2-7.
84. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46(3):225-251.
85. Scheff S.W., Rabchevsky A.G., Fugaccia I., Main J.A., Lumpp J.E. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 2003, 20:179-193.
86. Sharp K.G., Flanagan L.A., Yee K.M., Steward O. A re-assessment of a combinatorial treatment involving Schwann cell transplants and elevation of cyclic AMP on recovery of motor function following thoracic spinal cord injury in rats. Exp. Neurol. 2010, (ePub Dec. 30).
87. Smith G.M., Strunz C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 2005, 52:209-218.
88. Snow D.M., Lemmon V., Carrino D.A., Caplan A.I., Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 1990, 109:111-130.
89. Snow D.M., Letourneau P.C. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J. Neurobiol. 1992, 23:322-336.
90. Snow D.M., Mullins N., Hynds D.L. Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. Microsc. Res. Tech. 2001, 54:273-286.
91. Stallcup W.B., Beasley L. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J. Neurosci. 1987, 7:2737-2744.
92. Tang X., Davies J.E., Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71:427-444.
93. Thon N., Haas C.A., Rauch U., Merten T., Fassler R., Frotscher M., Deller T. The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur. J. Neurosci. 2000, 12:2547-2558.
94. Tom V.J., Steinmetz M.P., Miller J.H., Doller C.M., Silver J. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J. Neurosci. 2004, 24:6531-6539.
95. Vahidi B., Park J.W., Kim H.J., Jeon N.L. Microfluidic-based strip assay for testing the effects of various surface-bound inhibitors in spinal cord injury. J. Neurosci. Methods 2008, 170:188-196.
96. Viapiano M.S., Bi W.L., Piepmeier J., Hockfield S., Matthews R.T. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Res. 2005, 65:6726-6733.
97. Viapiano M.S., Matthews R.T., Hockfield S. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. J. Biol. Chem. 2003, 278(35):33239-33247.
98. Wang L., Hu B., Wong W.M., Lu P., Wu W., Xu X.M. Glial and axonal responses in areas of Wallerian degeneration of the corticospinal and dorsal ascending tracts after spinal cord dorsal funiculotomy. Neuropathology 2009, 29:230-241.
99. Waselle L., Quaglia X., Zurn A.D. Differential proteoglycan expression in two spinal cord regions after dorsal root injury. Mol. Cell. Neurosci. 2009, 42(4):315-327.
100. Wessels M., Lucas C., Eriks I., de G.S. Body weight-supported gait training for restoration of walking in people with an incomplete spinal cord injury: a systematic review. J. Rehabil. Med. 2010, 42:513-519.
101. White R.E., McTigue D.M., Jakeman L.B. Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice. J. Comp. Neurol. 2010, 518(8):1370-1390.
102. Yamada H., Fredette B., Shitara K., Hagihara K., Miura R., Ranscht B., Stallcup W.B., Yamaguchi Y. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J. Neurosci. 1997, 17:7784-7795.
103. Zuo J., Neubauer D., Dyess K., Ferguson T.A., Muir D. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp. Neurol. 1998, 154:654-662.